New diabetes clinical trial: FEAST and HOPE: Redox PSC Pilot Study
Published on: 2026-10-27T04:00:00Z
Conditions: Primary Sclerosing Cholangitis (PSC)
Interventions: Dietary Supplement: N-Acetyl Cysteine (NAC); Dietary Supplement: Alpha-Lipoic Acid (ALA); Dietary Supplement: Nicotinamide Riboside (NR); Drug: Metformin Hydrochloride Extended-Release Tablets; Other: Study Diet
Sponsors: Brigham and Women's Hospital
Not yet recruiting
https://ift.tt/nq0ikTR
Conditions: Primary Sclerosing Cholangitis (PSC)
Interventions: Dietary Supplement: N-Acetyl Cysteine (NAC); Dietary Supplement: Alpha-Lipoic Acid (ALA); Dietary Supplement: Nicotinamide Riboside (NR); Drug: Metformin Hydrochloride Extended-Release Tablets; Other: Study Diet
Sponsors: Brigham and Women's Hospital
Not yet recruiting
https://ift.tt/nq0ikTR
Comments
Post a Comment